These drug supply issues are a great opportunity to have patient management reviews, emphasise principles around healthy lifestyle, and review therapies including prescribing options or even de-prescribing if possible. Alternative treatment options suggested by the RACGP include: Liraglutide, which is administered once daily and has evidence of cardiovascular benefit, but is not subsidised by PBS SGLT-2 inhibitors, especially in those who also have cardiovascular disease, multiple cardiovascular risk factors and/or kidney disease DPP-4 inhibitors, which may be useful in those who do not have cardiovascular disease, multiple cardiovascular risk factors or kidney disease, and are unable to achieve optimal blood glucose levels Sulphonylureas or insulin (initiation or titrated doses), but these may lead to risks for hypoglycaemia and weight gain The twice daily exenatide (Byetta) is not recommended as a potential substitute, as it has been discontinued and is also no longer available
How L-Carnitine Enhances the Keto Diet 1
2 Complimentary mental well-being membership Subscription to the meQuilibrium app to support your mental well-being, build resiliency and manage day-to-day stress, all at no extra cost
We've seen firsthand how low-quality peptides can derail promising research, and we've built our entire operation to prevent that from happening to our clients
Massachusetts has been beset by drug rings like these
